A Trial to Evaluate the Efficacy, Safety and Tolerability of Subcutaneous TRV250

Summary

A trial to assess the efficacy, safety, tolerability and effect of a drug (code name TRV250) given as an injection to subjects who have received an injection of a drug called glyceryl trinitrate (GTN) which is clinically known to induce an immediate headache of short duration (under 30 minutes), known as the "GTN immediate headache"

Timeline

Start

2019-11-11

Primary completion

2020-02-17

Completion

2020-08-10

Outcome

Outcome not reported

Stopped (Enrollment): “Because there have been significant enrollment struggles which has been exacerbated by the COVID impact. This has caused an undue delay to the study timelines and its enrollment goals beyond the business needs.”

Drugs

Indications